These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 26806835)

  • 1. Epigenetic regulation of the thioredoxin-interacting protein (TXNIP) gene by hyperglycemia in kidney.
    De Marinis Y; Cai M; Bompada P; Atac D; Kotova O; Johansson ME; Garcia-Vaz E; Gomez MF; Laakso M; Groop L
    Kidney Int; 2016 Feb; 89(2):342-53. PubMed ID: 26806835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic regulation of glucose-stimulated osteopontin (OPN) expression in diabetic kidney.
    Cai M; Bompada P; Atac D; Laakso M; Groop L; De Marinis Y
    Biochem Biophys Res Commun; 2016 Jan; 469(1):108-113. PubMed ID: 26592666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone acetylation of glucose-induced thioredoxin-interacting protein gene expression in pancreatic islets.
    Bompada P; Atac D; Luan C; Andersson R; Omella JD; Laakso EO; Wright J; Groop L; De Marinis Y
    Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):82-91. PubMed ID: 27989964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thioredoxin-Interacting Protein Deficiency Protects against Diabetic Nephropathy.
    Shah A; Xia L; Masson EA; Gui C; Momen A; Shikatani EA; Husain M; Quaggin S; John R; Fantus IG
    J Am Soc Nephrol; 2015 Dec; 26(12):2963-77. PubMed ID: 25855771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High glucose-induced thioredoxin-interacting protein in renal proximal tubule cells is independent of transforming growth factor-beta1.
    Qi W; Chen X; Gilbert RE; Zhang Y; Waltham M; Schache M; Kelly DJ; Pollock CA
    Am J Pathol; 2007 Sep; 171(3):744-54. PubMed ID: 17675577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thioredoxin interacting protein (TXNIP) induces inflammation through chromatin modification in retinal capillary endothelial cells under diabetic conditions.
    Perrone L; Devi TS; Hosoya K; Terasaki T; Singh LP
    J Cell Physiol; 2009 Oct; 221(1):262-72. PubMed ID: 19562690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of thioredoxin-interacting protein improves cardiac inotropic reserve in the streptozotocin-induced diabetic heart.
    Myers RB; Fomovsky GM; Lee S; Tan M; Wang BF; Patwari P; Yoshioka J
    Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1748-59. PubMed ID: 27037370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiomyocyte-specific Txnip C247S mutation improves left ventricular functional reserve in streptozotocin-induced diabetic mice.
    Mukai N; Nakayama Y; Abdali SA; Yoshioka J
    Am J Physiol Heart Circ Physiol; 2021 Aug; 321(2):H259-H274. PubMed ID: 34085839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A possible role of thioredoxin interacting protein in the pathogenesis of streptozotocin-induced diabetic nephropathy.
    Hamada Y; Fukagawa M
    Kobe J Med Sci; 2007; 53(1-2):53-61. PubMed ID: 17582205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIRT6-mediated transcriptional suppression of Txnip is critical for pancreatic beta cell function and survival in mice.
    Qin K; Zhang N; Zhang Z; Nipper M; Zhu Z; Leighton J; Xu K; Musi N; Wang P
    Diabetologia; 2018 Apr; 61(4):906-918. PubMed ID: 29322219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of histone acetyltransferase by naringenin and hesperetin suppresses Txnip expression and protects pancreatic β cells in diabetic mice.
    Wang SW; Sheng H; Bai YF; Weng YY; Fan XY; Zheng F; Fu JQ; Zhang F
    Phytomedicine; 2021 Jul; 88():153454. PubMed ID: 33663922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired cardiac anti-oxidant activity in diabetes: human and correlative experimental studies.
    Connelly KA; Advani A; Advani SL; Zhang Y; Kim YM; Shen V; Thai K; Kelly DJ; Gilbert RE
    Acta Diabetol; 2014 Oct; 51(5):771-82. PubMed ID: 24925443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An analysis of high glucose and glucosamine-induced gene expression and oxidative stress in renal mesangial cells.
    Cheng DW; Jiang Y; Shalev A; Kowluru R; Crook ED; Singh LP
    Arch Physiol Biochem; 2006; 112(4-5):189-218. PubMed ID: 17178593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical role for thioredoxin-interacting protein in diabetes-related impairment of angiogenesis.
    Dunn LL; Simpson PJ; Prosser HC; Lecce L; Yuen GS; Buckle A; Sieveking DP; Vanags LZ; Lim PR; Chow RW; Lam YT; Clayton Z; Bao S; Davies MJ; Stadler N; Celermajer DS; Stocker R; Bursill CA; Cooke JP; Ng MK
    Diabetes; 2014 Feb; 63(2):675-87. PubMed ID: 24198286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TXNIP mediated the oxidative stress response in glomerular mesangial cells partially through AMPK pathway.
    Xu W; Wang L; Li J; Cai Y; Xue Y
    Biomed Pharmacother; 2018 Nov; 107():785-792. PubMed ID: 30142540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic memory in kidney diseases.
    Mimura I
    Kidney Int; 2016 Feb; 89(2):274-7. PubMed ID: 26806830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein.
    Schulze PC; Yoshioka J; Takahashi T; He Z; King GL; Lee RT
    J Biol Chem; 2004 Jul; 279(29):30369-74. PubMed ID: 15128745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thioredoxin interacting protein expression in the urinary sediment associates with renal function decline in type 1 diabetes.
    Monteiro MB; Santos-Bezerra DP; Thieme K; Admoni SN; Perez RV; Machado CG; Queiroz MS; Nery M; Oliveira-Souza M; Woronik V; Passarelli M; Giannella-Neto D; Machado UF; Corrêa-Giannella ML
    Free Radic Res; 2016; 50(1):101-10. PubMed ID: 26480949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression, localization, and function of the thioredoxin system in diabetic nephropathy.
    Advani A; Gilbert RE; Thai K; Gow RM; Langham RG; Cox AJ; Connelly KA; Zhang Y; Herzenberg AM; Christensen PK; Pollock CA; Qi W; Tan SM; Parving HH; Kelly DJ
    J Am Soc Nephrol; 2009 Apr; 20(4):730-41. PubMed ID: 19211714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ChREBP deficiency alleviates apoptosis by inhibiting TXNIP/oxidative stress in diabetic nephropathy.
    Chen N; Song S; Yang Z; Wu M; Mu L; Zhou T; Shi Y
    J Diabetes Complications; 2021 Dec; 35(12):108050. PubMed ID: 34600826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.